Cargando…
Dendritic Cell Therapies for Hematologic Malignancies
Dendritic cells (DCs) are potent antigen-presenting cells that constitute a major component of the immune system’s role in the recognition, elimination, and tolerance of cancer. The unique immunologic capabilities of DCs have recently been harnessed for therapeutic use with the creation of DC-based...
Autores principales: | Weinstock, Matthew, Rosenblatt, Jacalyn, Avigan, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415319/ https://www.ncbi.nlm.nih.gov/pubmed/28480306 http://dx.doi.org/10.1016/j.omtm.2017.03.004 |
Ejemplares similares
-
Dendritic Cell Cancer Vaccines: From the Bench to the Bedside
por: Katz, Tamar, et al.
Publicado: (2014) -
Immunotherapy for the treatment of multiple myeloma
por: Boussi, Leora S., et al.
Publicado: (2022) -
CAR T-Cell Therapy in Hematological Malignancies
por: Haslauer, Theresa, et al.
Publicado: (2021) -
The Hematology of Tomorrow Is Here—Preclinical Models Are Not: Cell Therapy for Hematological Malignancies
por: Arranz, Lorena
Publicado: (2022) -
Dendritic cell defects in patients with cancer: mechanisms and significance
por: Lenahan, Corrine, et al.
Publicado: (2006)